EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable

Alexander Viloria Winnett iD, Timothy Stenzel iD, Rustem F Ismagilov iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Alexander Viloria Winnett und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA. Hauptthemen laut MEDLINE: COVID-19, Pharynx, Specimen Handling, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, California Institute of Technology, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of severe acute respiratory syndrome coronavirus 2 infection by diagnostic tests can prompt actions to reduce transmission and improve treatment efficacy, especially for vulnerable groups such as immunocompromised individuals. Recent evidence suggests that sampling the throat in addition to the nose improves clinical sensitivity during early infection for both antigen and molecular coronavirus disease 2019 tests. We urge test manufacturers to validate tests for use with throat swab, in combination with nasal swabs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PharynxSpecimen HandlingSARS-CoV-2NoseHumansCOVID-19 TestingSensitivity and SpecificityEarly Diagnosis

Stichwörter der Autor:innen

COVID-19early detectionrapid diagnosticsspecimen typesvalidation testing

Autor:innen und Institutionen

  • Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California, USA.
  • Division of Biology & Biological Engineering, California Institute of Technology, Pasadena, California, USA.
  • California Institute of Technology Medical Scientist Training Program, University of California Los Angeles, Los Angeles, California, USA.
  • Office of In Vitro Diagnostics, US Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Alexander Viloria Winnett, Timothy Stenzel, Rustem F Ismagilov

Förderung

  • NIAID NIH HHS
  • California Institute of Technology
  • Bill & Melinda Gates Foundation

Zitieren

APA

Viloria Winnett, A., Stenzel, T., & Ismagilov, R. F. (2024). Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae381

Vancouver

Viloria Winnett A, Stenzel T, Ismagilov RF. Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae381

BibTeX
@article{ViloriaWinnett2024,
  author = {Viloria Winnett, Alexander and Stenzel, Timothy and Ismagilov, Rustem F},
  title = {Validating Combination Throat-Nasal Swab Specimens for Coronavirus Disease 2019 Tests Would Improve Early Detection, Especially for the Most Vulnerable},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae381}
}
Kostenlos starten →